首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 醫藥品企業新的多管道行銷策略
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

醫藥品企業新的多管道行銷策略

New Multi-Marketing Channel Strategies

出版商 Datamonitor
出版日期 2009年08月 商品編碼 99200
內容資訊 英文 57 pages
價格
US $ 3800 PDF by E-mail (Single User License)
US $ 9500 PDF by E-mail (Corporate Use License)


醫藥品企業新的多管道行銷策略 是由出版商Datamonitor在2009年08月所出版的。 這份英文市場調查報告書包含57 pages 價格從美金3800起跳。

目錄

Abstract

Introduction

The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited.

Scope of this research

  • Provides an overview of the reasons behind the need for new marketing channels
  • Explores the different channel mixes used to reach the pharma industry' s diverse customer base, both patients and doctors
  • Examines the use of online social media technology and uses in-depth case study analysis to examine the pros and cons of each marketing channel
  • Evaluates the future of online technology and how it can be used by Pharma marketing teams

Research and analysis highlights

Social media is an excellent communication medium for pharma companies wishing to interact with patients, incorporating both disease and product information. The informal relaxed setting suits the more emotive informational needs of patients.

The key for the industry now is to strike the right balance between use of new media tools and deciding which aspects of traditional marketing strategies should remain or can be modified to suit today' s marketing environment.

Using online technology such as eDetailing is the most effective online marketing tool for physicians, and can be used to create an effective closed-loop marketing strategy as part of a viable and sensible approach to successful physician marketing.

Key reasons to purchase this research

  • Understand why marketing practices in the pharmaceutical industry is changing
  • Access actionable recommendations through case study analysis on the appropriateness of eMedia strategies towards different target audiences.
  • Identify future models that Pharma companies could consider replicating going forward

Table of Contents

EXECUTIVE SUMMARY

  • Strategic scoping and focus
  • Datamonitor insight
  • Related reports

CHAPTER 2 EXAMINING THE NEED FOR A MULTI-CHANNELED MARKETING APPROACH

  • Traditional physician and patient marketing channels are becoming less effective
  • A multi-marketing channel approach is the way forward
    • Multi-channel marketing requires a tailored mix of traditional and novel media aimed at each target audience
  • Multi-channel marketing channels need to be considered in terms of targeted customers
    • New multiple-marketing channels need to be considered in terms of the healthcare professional targeted
    • New multiple-marketing channels need to be considered for patients too

WEB 2.0 TECHNOLOGY - A KEY COMPONENT OF MULTI-CHANNEL MARKETING

  • Pharma needs to be where its customers are - online
  • Web 2.0 technology enables Pharma to communicate with patients
    • YouTube - a underused communication tool
    • Pharma' s use of Facebook is still in its infancy
    • MySpace is not used by Pharma
    • Twitter - Pharma likes to Tweet!
    • Blogs are still a one-way communication method
    • Web 2.0 technology is not being used effectively as a promotional tool to target healthcare professionals
  • Opportunities for Pharma to create an integrated disease management program around its drugs
    • Google Health - personalized medicine will be the future
    • iPhone (smart-phone) applications - replacement educational incentive for reps seeking physician access
    • Wii Fit - a communication tool

BIBLIOGRAPHY

  • Publications and online articles
  • Datamonitor resources

APPENDIX

  • Search advertisement
  • Sponsored link
  • Web 2.0

TABLES

  • Table: Marketing approaches to key stakeholders
  • Table: Online physician and nurse communities, 2009
  • Table: Top 10 Pharma company websites visited by US physicians, 2008
  • Table: Brand sponsored patient communities
  • Table: Top 10 Big Pharma companies with the highest promotional spend, 2008
  • Table: Pharma companies with a presence on YouTube, 2009
  • Table: Big Pharma companies with corporate - employee Facebook pages (as of July 2009), 2009
  • Table: Pharma sponsored Facebook pages
  • Table: List of Pharma companies with Twitter accounts
  • Table: Pharma blogs - corporate and branded drug blogs sites currently in operation, 2009
  • Table: Top 10 iPhone health-related applications

FIGURES

  • Figure: Big Pharma companies ranked by their 2007 advertising budgets, 2006 - 07
  • Figure: Multi-channel marketing combines traditional and novel (web - based) approaches
  • Figure: Internal cross-functional teamwork necessary for multi-channel marketing strategy
  • Figure: Optimizing Pharma- physician communication channel strategies
  • Figure: An outline of the FDA' s draft guidelines on presenting risk information in prescription drug and medical device promotional material
  • Figure: The pros and cons of YouTube as a means for pharma companies of raising both disease and product awareness among patients
  • Figure: Johnson & Johnson' s YouTube page
  • Figure: The pros and cons of a pharma Facebook profile as part of Pharma' s patient marketing strategy
  • Figure: Novartis-sponsored patient advocate Facebook page by Marcia Strassman, 2009
  • Figure: Twitter, MySpace and Facebook audience retention rates
  • Figure: The pros and cons for pharma companies f of a Twitter account
  • Figure: Boehringer Ingelheim' s Twitter page user occupation and online behaviors
  • Figure: Alli connect - GlaxoSmithKline' s honest blogging webpage)
Back to Top